LobbyingMako Medical Laboratories lobbying by quarter
Mako Medical Laboratories's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs and Health Issues.
Mako Medical Laboratories
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $120K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $40K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $0 | 0 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $80K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$120K · 2 reports
- Health issues$60K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)2 reports
- Health & Human Services, Dept of (HHS)2 reports
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Checkmate Government Relations | $120K | 2 quarters |
| Linchpin Strategies | $60K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Checkmate Government Relations | $80K |
| 04/19for Q1 | Checkmate Government Relations | $40K |
| 04/14for Q1 | Checkmate Government Relations | Under $5,000 |
| 23/04/19for Q1 2023 | Linchpin Strategies | $20K |
| 23/01/18for Q4 2022 | Linchpin Strategies | $40K |